EMBECTA CORP. (EMBC) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 139.40M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 1.32B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.27B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $139.40M | $1.32B | (m) | (m) | $1.27B | (m) |
| 2026-03-31 | (m) | (m) | $9.50M | $1.32B | (m) | (m) | $1.03B | (m) |
| 2025-12-31 | (m) | (m) | $9.50M | $1.35B | (m) | (m) | $1.06B | (m) |
| 2025-09-30 | (m) | (m) | $9.50M | $1.39B | (m) | (m) | $1.09B | (m) |
| 2025-06-30 | (m) | (m) | $9.50M | $1.46B | (m) | (m) | $1.16B | (m) |
| 2025-03-31 | (m) | (m) | $9.50M | $1.51B | (m) | (m) | $1.12B | (m) |
| 2024-12-31 | (m) | (m) | $9.50M | $1.53B | (m) | (m) | $1.15B | (m) |
| 2024-09-30 | (m) | (m) | $9.50M | $1.57B | (m) | (m) | $1.29B | (m) |
| 2024-06-30 | (m) | (m) | $9.50M | $1.59B | (m) | (m) | $1.27B | (m) |
| 2024-03-31 | (m) | (m) | $9.50M | $1.59B | (m) | (m) | $1.20B | (m) |
| 2023-12-31 | (m) | (m) | $9.50M | $1.59B | (m) | (m) | $1.22B | (m) |
| 2023-09-30 | (m) | (m) | $9.50M | $1.59B | (m) | (m) | $1.21B | (m) |
| 2023-06-30 | (m) | (m) | $9.50M | $1.59B | (m) | (m) | $1.25B | (m) |
| 2023-03-31 | (m) | (m) | $9.50M | $1.60B | (m) | (m) | $1.21B | (m) |
| 2022-12-31 | (m) | (m) | $9.50M | $1.60B | (m) | (m) | $1.20B | (m) |
| 2022-09-30 | (m) | (m) | $9.50M | $1.60B | (m) | (m) | $1.09B | (m) |
| 2022-06-30 | (m) | (m) | $9.50M | $1.60B | (m) | (m) | $1.05B | (m) |
| 2022-03-31 | (m) | (m) | $9.50M | $1.40B | (m) | (m) | $833.50M | (m) |
| 2021-09-30 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $788.00M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |